Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in Asia

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Life science startups based in Asia. We rank investors based on the number of investments they made in Life science companies from Asia. We update this investor list every month.

Top 50 Life Science Startup Investors in Asia

Investor	Life Science Asia investments
Hillhouse Investment	6
Sequoia Capital China	5
Prox Ventures	5
Osaka University Venture Capital	4
Mitsubishi UFJ Capital	4
Qiming Venture Partners	4
EFung Capital	4
Huagai Capital	4
SMBC Venture Capital	3
ULTIMA	3
Entrepreneurship Relay Group	3
WuXi AppTec	3
BioVenture	3
Nissay Capital	3
Nippon Venture Capital	3
Legend Capital	3
Anzu Partners	3
EDBI	3
Gaw Capital Partners	2
Real Tech Japan	2
Senshu Ikeda Capital	2
Huimei Capital	2
CentreGold Capital	2
Eight Roads Ventures	2
Eisai	2
ASBV	2
Orient Securities Capital Investment	2
Lilly Asia Ventures	2
Sherpa Venture Capital	2
Highlight Capital	2
MiraclePlus	2
Incubate Fund	2
Oriental Fortune Capital	2
Mizuho Capital	2
Lucion	2
BOHE Angel Fund	2
CD Capital	2
Green Pine Capital Partners	2
SBI Investment	2
Med-Fine Capital	2
Zoo Capital	2
Bits x Bites	2
Loyal Valley Capital	2
Hana Financial Investment	1
Starlight Capital	1
CareNet	1
Wanwu Capital	1
Tsing-Yuan Capital	1
Future Venture Capital	1
Country Garden Venture Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Hillhouse Capital Group is an investment management firm that invests with a long-term time horizon. Hillhouse owns companies across equity stages, spanning the range from new start-ups to the world’s most established public companies. It may invest in a company as a start-up and continue to hold it in the portfolio as a public equity investment.This stage-agnostic investment style allows them to focus on multi-year results, rather than on quarterly earnings.Hillhouse Capital Group invests globally, with a particular focus on Asia. Independent, proprietary research lies at the heart of our investment process. Our team members are sector experts in consumer, Internet, media, and healthcare. Hillhouse Capital Group was founded in 2005 and is based in Beijing, China.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, India

Portfolio highlights

Tenways — TENWAYS Electric Bikes with multi-scenario applications for superior value, light weight, quick charge and instant assistance. For commuting, lifestyle, exercising and more.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Deep Vision Intelligence — Deep Vision Intelligence is a developer of embedded machine vision products.

We help founders build enduring companies.

Investment focus

Biotechnology, Health Care, Software
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

Black Jade Star Rock — Black Jade Star Rock develops organoid-based intelligent equipment and chips. It is a biomedical research and development company with organoid science as its fundamental technology.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.
Membrane Biofilm Technology — Membrane Biofilm Technology is a membrane filtration company that specializes in the development, production, and solutions of membrane filtration products.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
Japan

Portfolio highlights

EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
Thinker — Thinker provides sales of proximity sensors and proposed solutions using these products.
Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series B, Series A
Japan, United States, China

Portfolio highlights

Parallel — Parallel Inc. develops a parallel SNS which can be used while playing games on smartphones.
Swell — Swell is an information technology company that specializes in providing web and digital platforms.
GenerativeX Co — GenerativeX provides AI app development, consulting, and generative model development.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Ruining Bio — Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Silicon Yi Technology — Silicon Yi Technology is an RNA nano-pesticide research and development firm.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Turno — Turno Finance makes owning EV very affordable. Turno Club is a community around commercial EVs. Turno Battery Future is our solution to keeping batteries on the road for longer.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Huayuan Regenerative Medicine — Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Investment focus

Information Technology, Health Care, Software
Funding Round, Series B, Series A
Japan, United States, Mexico

Portfolio highlights

Ababa — Ababa provides recruitment and employment solutions.
HarvestX — HarvestX manufactures fully automatic robots which contributes to the shortage of agricultural human resources and stable food production
Smartpay — Smartpay is the first free of charge BNPL payment option for Japanese consumers who have credit cards. There are no sign-up fees, interest fees, settlement fees, or late charges. The payment experience is also Japan’s first cross-merchant, cross-platform, and single-click checkout BNPL service, allowing consumers to checkout in as little as 10seconds. The BNPL payment solution is simple to understand, structured on 3 equal installments over 8 weeks. This means that unlike the existing BNPL services in Japan, customers do not need to go to the convenience store to make payments or pay any bank transfer fees.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Medical, Life Science, Biotechnology
Series A, Angel, Series C
China

Portfolio highlights

Bangqi Biological — Bangqi Biological is a biotechnology company that focuses on the research and development, production, registration, quality, supply chain and sales of instruments and reagents for autoimmunity & allergy diagnosis.
Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
Lingyun Microelectronics — Lingyun Microelectronics is a manufacturer of high-speed digital-analog hybrid interfaces and control processors.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States

Portfolio highlights

Dodai — Dodai manufactures and assembles the electric motorcycles.
Yap — Yap helps pharmaceutical businesses enter the market in a multitude of methods.
Pocket Sign — Pocket Sign develops digital platforms that store e-signatures and other authentication details for it's users privacy and security.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Issues — Issues provides development and management of web service issues that solve the problems.
Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

MS Energy — MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.
Dearer Medical — Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses.
Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Manufacturing, Software
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

Aspinity — Aspinity offers neuromorphic all-analog integrated circuit technology that can replicate the functionality of digital signal processors. It reduces the system power requirements for always-on sensing applications.Their vision is that battery life does not have to stand in the way.It was founded in 2015 and headquartered in Pittsburgh,Pennsylvania.
EnCharge AI — AI Compute from the Edge-to-Cloud for Every Business. Transformative technology for AI computation, breaking records in efficiency and sustainability to enable state-of-the-art models uninhibited by power, space, and cost constraints.
AM Batteries — AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology. The company was founded in 2016 and is headquartered in Chelmsford, Massachusetts.

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, China

Portfolio highlights

LXA — LXA operates as a fintech company, that focus on reimagining of Asia's mortgage ecosystem.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
Engine Biosciences — We digitize and decipher complex biology with cutting-edge technologies to discover and develop life-changing medicines.

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Investment focus

Information Technology, Hotel, Property Management
Series A, Seed, Series B
China, Singapore, United States

Portfolio highlights

Blackpanda — Asia's premier digital forensics and cyber incident response firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Gusto Collective — First brandtech group using the latest technology to help brands create content and experiences across the physical and virtual worlds.

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Series A, Seed
Japan, Singapore, Austria

Portfolio highlights

Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
ProfilePrint — Helping agribusinesses buy and sell better, ProfilePrint is powered by a patented digital food identity-as-a-service (IDaaS) technology. ProfilePrint synthesises complex molecular data of ingredient samples into digital fingerprints, rapidly predicting its identity and quality.
Integriculture — Integriculture makes cellular agriculture products to improve sustainability, food security, and reduce public health problems. The company offers a developed patented general-purpose large-scale cell culture system that can culture wide range of cells without external addition of expensive growth factors and provide consumers with affordable cleanmeat.Founded in 2015, Integriculture is headquartered in Tokyo, Japan.

Senshu Ikeda Capital offers financial consultancy services.

Investment focus

Software, Internet, Information Technology
Funding Round, Seed, Series A
Japan

Portfolio highlights

Sagri — Sagri is developing agriculture software for experienced farmers.
BABY JOB — BABY JOB offers nursery support and child care support businesses.
On The Slope — On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Zilixir Biotech — Zilixir Biotech develops a new protein design technology that offers possibilities for human exploration of the complex life sciences. SWORD™ protein design technology integrates binding pockets, new drug skeleton design, activity prediction, ADME/T prediction, etc., and has had some achievements in these areas, fully demonstrating theeffectiveness of protein design.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

HiLabs — A Monetizable Artificial Intelligence Platform
EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
Shadowfax — Best last mile delivery service provider across Food, E-commerce, Groceries, Pharma, FMCG, Consumer durables, Auto, BFSI, Telecom, Freight forwarding & Apparel.

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Ractigen Therapeutics — Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.
LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Service Industry
Series A, Seed, Angel
China

Portfolio highlights

Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Huasaiboman Medical Cell Biology — Warseeberman is a cell therapy solution provider, focusing on new cell therapy technologies, based on clinical research, and dedicated to the development of immune cell drug products for the treatment of solid tumors and stem cell therapy products for the treatment of degenerative diseases. The company aims at the cutting-edge technology of tumorimmunotherapy, focuses on the development of tumor infiltrating lymphocyte (TIL) drugs for solid tumors, and cooperates with many hospitals to establish a solid tumor and clinical transformation research institute, dedicated to bringing life to solid tumor patients Hope.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Health Care, Manufacturing, Software
Series A, Series D, Series C
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Targeting One — Targeting One is an in-vitro diagnostic product developer.
Comanche Biopharma — Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia. The company aims to lower the risks of pregnancy and prematurity by safely sustaining natural pregnancy and allowing fetal maturation.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
China, United States, Portugal

Portfolio highlights

EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
Hydropeng Technology — Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems thatfulfill the green energy demands of global ESG development.
Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

Kanaries — Kanaries is a company in automated data science that specializes in enhanced analytical data services. Its solutions include the RATH intelligent data analysis platform and the pygwalker open source data visualization tool, among others, which use AI, causal inference, and an intelligent visualization engine for aid.
Chipfy Technology — Chipfy Technology is an integrated circuit design network solutions company that focuses on providing chip IP design services for high-speed interfaces.
RWKV Yuanshi Intelligence — RWKV Yuanshi Intelligence is a domestic open source provider of huge language models with non-Transformer architecture. Its solutions combine the benefits of Transformer and RNN: high and consistent inference efficiency, low and consistent graphics memory utilization, support for unbounded context, and chip compatibility.

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

Investment focus

Software, E-Commerce, Information Technology
Seed, Funding Round, Series A
Japan, United States, India

Portfolio highlights

SoftRoid — SoftRoid provides a software robot that patrols and collects data for analyzing the construction site.
M-INT — M-INT is a life science company that offers medical infrastructure and medical IT system.
Blossom Energy — Developed advanced nuclear reactors that are able to produce clean energy, Blossom Energy manufactures nuclear reactors for the nuclear energy industry. The focus of the company is on providing affordable, stable, and sustainable energy for the world. The company utilizes HTGR, which is a fourth-generation nuclear reactor.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Information Technology, Manufacturing
Series A, Series B, Seed
China, United States

Portfolio highlights

Renshuo Solar — Renshuo Solar is a manufacturer of perovskite tandem solar panels.
Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Investment focus

Information Technology, Software, Internet
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

Japan DX — Japan DX platform provides a comprehensive data-driven services to inbound tourists to Japan.
Unito — Unito offers people a friction-free lifestyle by pursuing optimization of living.
GenerativeX Co — GenerativeX provides AI app development, consulting, and generative model development.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Manufacturing, Medical
Series A, Series B, Seed
China

Portfolio highlights

Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
ThunderBio Innovation — ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Seed, Series A
China

Portfolio highlights

Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
Singlomics — Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
Shuimu BioSciences — Shuimu BioSciences Ltd. was founded in 2017 in Beijing, China, to bring the power of Cryo-EM to new therapeutics developers through a differentiated service offering, making the method accessible and affordable for Discovery teams at all stages of method adoption. We are the first commercial full service Cryo-EM platform in Asia, led by top expertsfrom Tsinghua University and experienced industry executives. All of our work is performed with the quality controls and service levels expected of a top tier contract research organization.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Kanova — Kanova is a biopharmaceutical firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Green Pine Capital Partners is a venture capital firm.

Investment focus

Artificial Intelligence, Manufacturing, Software
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Biodep — Biodep produces probiotics and derivatives, which are used in meals, healthy foods, cosmetics, environmental remediation, contemporary agriculture, and other industries.
Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Guorui Xiechuang — Guorui Xiechuang is a joint venture subsidiary of Betterray New Materials Group Co., Ltd., provides power + energy storage products and system integration solutions for global customers.

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Financial Services, Software, Information Technology
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States

Portfolio highlights

Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Investment focus

Artificial Intelligence, Software, Biotechnology
Seed, Series A, Series B
China, Hong Kong, United States

Portfolio highlights

TabbyML — LLM x DevTools + OpenSource
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Investment focus

Biotechnology, Food and Beverage, Food Processing
Series A, Seed, Series B
China, Israel, Singapore

Portfolio highlights

Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
Mojia Bioscience — Mojia Bioscience is a biotechnology company.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

Loyal Valley Capital is a thematic, research-driven private equity firm.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series C, Series B, Series A
China, United States, Hong Kong

Portfolio highlights

Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.
Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Investment focus

Information Technology, FinTech, Financial Services
Series A, Funding Round, Seed
South Korea, Singapore, India

Portfolio highlights

Trustay — Trustay is a real estate asset management company.
AIZEN Global — AIZEN is redesigning Digital Banking with CreditConnect, powered by our proprietary ABACUS AutoML platform specialized in the financial services industry. CreditConnect is an AI lending platform designed to bridge the gap between banks and data economy platforms, and automate key decision-making processes in accordance with the credit cycle. Thecompany has secured Series B round funding from a state-led fintech innovation fund (K-Growth) led by major Korean banks to roll out CreditConnect in Southeast Asia.We are also leading the digital transformation in the financial services industry using proprietary AutoML platform ABACUS, with successful use cases in underwriting, fraud detection, product development, claim analysis, and more.
Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.

Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.

Investment focus

Software, Agriculture, Life Science
Series A
China

Portfolio highlights

JJC TEC — JJC TEC is an intelligent equipment manufacturer that focuses on the R&D and technical services of intelligent drilling robots and systems in the petroleum industry.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Yunna Technology — Yunna Technology is a provider of intelligent software technology products and services.

CareNet is a marketing company providing various solutions to pharma companies through the management of media specialized in medical/pharmaceutical education for HCPs. For more than 20 years and since its foundation in 1996, CareNet has continually provided places for exchanging therapeutic information, as well as valuable solutions to HCPsand pharmaceutical companies from the position of the No. 1 media in clinical medical education.

Investment focus

Life Science, Biotechnology, Health Care
Series A, Series B, Series C
Japan, United States

Portfolio highlights

Modalis Therapeutics — Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
DiscGenics — DiscGenics is focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.

Wanwu Capital is an investment firm

Investment focus

Artificial Intelligence, Agriculture, SaaS
Series A, Funding Round, Seed
China

Portfolio highlights

Mogic AI — Mogic AI is an advertising technology platform that provides tools to create and launch campaigns by pulling product images into ads using AI.
Huida Tech — Heilongjiang Huida Technology Development Co., Ltd. is a developer of agricultural machinery operation detection equipment. It focuses on the combination of Internet technology and smart agriculture, and provides agricultural production efficiency and management level through information technology. It is a leading domestic agricultural machineryinformatization solution. provider.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Tsing-Yuan Capital is a Chinese venture capital firm specialized in early, middle, and mature stage investments.

Investment focus

Manufacturing, Health Care, E-Commerce
Series A, Angel, Series B
China, United States

Portfolio highlights

Soundec — Soundec is an enterprise that focuses on acoustic research and commercialization. The company's products include modules containing software algorithms and audio processing chips, which are mainly used in wired digital headphones and Bluetooth wireless headphones.
cheaptrustedpharmacy — 4B Technologies is a biotech company that develops novel medicines for neurodegenerative diseases and neurological injuries. Its drug development focuses on reliving pain symptoms from nervous system diseases such as stroke and glaucoma, enabling healthcare professionals to prescribe more effective treatments to their patients.The company wasfounded in 2017 and is based in Suzhou, China.
Yishi Technology — Yishi Technology is a 3D vision laser sensor R&D manufacturer dedicated to the research and development of intelligent industrial cameras

Future Venture Capital Co., Ltd. is a venture capital firm specializing in early stage investment. The firm invests in diversified investment in a broad range of industrial sectors. It seeks to invest in Japan. The firm prefers to be the lead investor in its portfolio companies. Future Venture Capital Co., Ltd. was founded in 1998 and is based inKyoto, Japan with offices in Tokyo, Aomori, Iwate, Yamagata, Kanazawa, Mie, Sakai, Kobe, and Ehime.

Investment focus

Information Technology, Manufacturing, Health Care
Funding Round, Seed, Series A
Japan, United States, Myanmar

Portfolio highlights

Torana — Torana provides "Toysub!" well known as educational toy subscription service in Japan market. We plan to go global and will be more bigger market share holder in East Asia. We collect month-age base toy feedback data and children's development status information. We plan best combination of toys and deliver. Customer returns and getsnew toys which fit children's growth and it is eco friendly service. We plan to build our own brand toys based on massive customer feedback and growth data and enter D2C market.
LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.
IGNITE IMPULSE, INC. — As a digital agricultural enhancing service, Ignite impulse offers a variety of services, some of which include the following: agricultural software and equipment rentals, sales, maintenance, and leasing solutions; self-regulated farm shells with pre-installed vertical farming solutions; machined irrigation consulting and installations; artificialintelligence (AI) powered farming solutions; hydroponics farming consultation- partnership and installations; supply chain and logistics partnership; and more.Ignite Impulse also offers hydroponics solutions, as well as controlled farming assistance and consulting, to corporate, government, and educational organizations as part of our cooperation with these entities.

Country Garden Ventures was established in January 2019. It is a first-level business unit of Country Garden Group. It is responsible for the group's equity investment business in addition to real estate investment. Since its establishment, Country Garden Ventures has always adhered to the investment strategy of “industry empowerment andvalue co-creation”, paying equal attention to financial investment and holding investment, and has initially formed a staged, dedicated track, and multi-level investment portfolio. Up to now, the team has accumulatively invested in many star companies such as Shell Search, Qinhuai Data, Ziguang Zhanrui, Penguin Almond, Hobo Pharmaceutical, Blue Arrow Aerospace, Xinruipeng Pet Medical, Lin Qingxuan and so on.

Investment focus

Manufacturing, Biotechnology, Hardware
Series A, Seed, Series B
China, France, Germany

Portfolio highlights

HemaCell — Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier.
PCG Power — PCG Power's vision is to stick to its core business of distributed power station investment and the long-term development direction of new energy system solution providers, to provide comprehensive and high-quality green energy and carbon-saving services to industrial and commercial owners, and to assist my country in achieving carbon peakingand carbon neutrality.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate